# The UK research-use-only debate

Canonical: https://europeanpeptideshop.com/blog/research-use-only-peptides-loophole/

Explore the catalogue and research library. Ordering and shipping have not opened yet.

Research news · 8 November 2026 · 2 min read · By [European Peptide Shop](https://europeanpeptideshop.com/about/)

### On this page

A University of Lincoln academic wants the UK to tighten the research use only loophole on peptides. Dr Luke Turnock told the BBC on 17 August 2026: tighter controls around research-only marketing should be an initial response.

## What is the research use only loophole?

Turnock, a senior lecturer in criminology, says sellers use research-only wording on product packaging. He says this may be used to attempt to avoid existing rules.

## How has the MHRA responded on research use only labels?

It decides on a case-by-case basis, and says: research-only wording does not decide classification when the presentation indicates a medicinal purpose. The BBC also reported the MHRA saying many peptides sold for recreational sport, "in the absence of medicinal claims, would not be considered medicines".

## Who else has raised it?

Prof Channa Jayasena of Imperial College London said the issue was "falling between the stools" of regulators. Luke Evans MP said the online sphere makes it "10 times worse".

None of these reports announces a change in the law. The ASA's [Pulse Report](https://europeanpeptideshop.com/blog/research-peptides-uk-asa-advertising-report/) made a related point about research use only wording, and the [legal guide](https://europeanpeptideshop.com/blog/human-medicines-regulations-2012-peptides/) covers the test.

## Scope for European readers

This is a dated account of the research or policy described in the linked sources. The stated jurisdiction, study product and population matter. A US or UK announcement does not establish authorisation or availability across Europe. Nothing in this report establishes results for an EPS catalogue material. Read the [research-use statement](https://europeanpeptideshop.com/research-use/) for the storefront's scope.

## Laboratory research only

Materials listed on this site are supplied for in-vitro laboratory research and are not for use in or on humans or animals. They are not medicines. This article summarises published work and gives no dosing, administration, treatment or in-vivo guidance. Findings from a study apply to the material and conditions of that study, and they say nothing about any product listed here.

## References

- [BBC via AOL, 17 August 2026](https://www.aol.com/articles/concern-over-online-peptides-sale-050452000.html)

- [Pharmacy Business, 14 July 2026](https://www.pharmacy.biz/unregulated-experimental-peptides-online/)

## More articles

Research news · 2 min read

## [Australia's Synedica peptide warning](https://europeanpeptideshop.com/blog/synedica-tga-warning-australia-tb-500/)

Australian testing found Synedica peptide products contained no TB-500 and less retatrutide than labelled. The TGA has told Australians to discard them.

8 November 2026

Research news · 3 min read

## [Avexitide and the LUCIDITY trial](https://europeanpeptideshop.com/blog/avexitide-glp-1-antagonist-lucidity/)

Why does avexitide block GLP-1? Explore post-bariatric hypoglycemia, LUCIDITY results and Amylyx’s November 2026 FDA-filing and conference plans.

8 November 2026

Research news · 3 min read

## [BPC-157: UK and US regulatory context](https://europeanpeptideshop.com/blog/is-bpc-157-legal-in-the-uk/)

The October 2026 US peptide policy is not UK authorisation. Read the MHRA classification framework and why research-use wording cannot settle a product's.

8 November 2026